Online communities like Reddit, Facebook, and condition-specific forums have not only given patients and caregivers a voice, they have also helped to increase awareness of dangerous drugs or defective medical devices.
Conversations in these communities have helped reveal adverse events that may not have been fully captured in product labeling but are being reported in real-time by real patients. They have also helped to surface potential issues with medical devices, sometimes well before formal regulatory reviews or recalls take place.
At Wisner Baum, our attorneys understand how effective these communities can be to help identify potential problems with prescription drugs and medical devices. We can also help patients understand whether their experiences warrant further evaluation.
Why Patient Stories Online Matter More Than Ever
For decades, patients and even health care providers have had limited access to independent information about the safety of drugs and medical devices. Pharmaceutical and device companies have historically exerted significant control over how safety information is communicated, and important details have not always reached patients or prescribers in a timely manner.
Today, however, patients are no longer limited to the information that manufacturers or the Food and Drug Administration (FDA) provide. Online communities now provide a space for people to share their experiences and ask questions. These conversations can serve as early-warning indicators for potential drug safety issues or medical device problems, including products that may have received expedited review through the FDA approval process.
While these communities do not replace the need for clinical trials or overshadow safety data, they provide a real-time glimpse of shared problems or experiences. Researchers and regulators now utilize these postings to find or confirm reports of adverse events instead of solely relying on traditional reporting methods.
From One Post To A Pattern: How Online Signals Form
The US Food and Drug Administration generally relies on self-reporting for adverse drug reactions (ADRs), which are unintended reactions from a particular drug. Unfortunately, this reporting can be delayed and may not be geographically diverse. A conversation in an online forum, on the other hand, can track side effects that may be happening in real-time. Over time, a single post can turn into a recognizable pattern.
What happens is a patient goes on a forum and posts about an odd side effect from a drug they are taking. Others chime in who may have experienced similar reactions. As the conversation grows, so does the reality that the symptom may be a reportable adverse drug reaction that the FDA, the drug manufacturer, or other parties need to take into consideration or issue a warning about.
Prior to the growth of online communities, patients may have felt that their problem was isolated. They may not have recognized that it was a symptom related to a particular drug and perhaps did not know about reporting methods or were unsure about whether to inform a healthcare provider. These conversations have helped, in some cases, to work as an early warning sensor.
Researchers have acknowledged that social media can sometimes identify drug safety issues, before formal databases recognize a pattern. Recognizing this, the FDA and other agencies have begun to consider using social media to get earlier insights into adverse events.
Case Example: Lead Migration And Device Complications In Spinal Cord Stimulator Communities
Spinal cord stimulator adverse events reported in online forums helped bring to light potential safety concerns involving spinal cord stimulators, implantable medical devices used to manage chronic pain by delivering electrical impulses to the spinal cord. In online communities, including this Reddit forum dedicated to spinal cord stimulation, patients have reported a range of experiences, including lead migration, electrical shocks, device malfunction, infection, and inadequate pain relief. These discussions often include detailed accounts of revision surgeries and, in some cases, complete device removal.
A 2026 study published in Regional Anesthesia & Pain Medicine analyzed 112 Reddit posts and 448 comments related to spinal cord stimulation. Researchers found that nearly half of users who commented on pain relief expectations reported experiencing considerably lower improvement than anticipated. Negative comments outnumbered positive ones, and commonly discussed adverse events included pocket pain, lead fracture or migration, infection risk, and scarring. The study’s authors concluded that social media platforms may offer valuable opportunities for healthcare professionals to better understand patient concerns.
These online reports have also informed broader investigative efforts. A 2018 investigation by the Associated Press — which sourced many of its patient interviews through online device forums — documented tens of thousands of adverse event reports related to spinal cord stimulators filed with the FDA.
The FDA subsequently reported receiving nearly 108,000 medical device reports related to spinal cord stimulators over a four-year period, including reports associated with hundreds of patient deaths. These findings underscore how online patient communities can surface safety signals that complement formal reporting systems.
Case Example: Accuracy Complaints In Dexcom CGM Communities
A real world example of how an online forum can help to detect problems with a medical device are threads related to the Dexcom continuous monitor systems. For months, users on r/dexcom shared specific complaints about the sensor's inaccuracy.
One user described the G7 as “seriously dangerous” because of its lack of accuracy. Another noted that all 5 of their G7 sensors either didn’t respond to calibrations or produced readings that were 40 points lower than their actual blood glucose levels. And yet another user found inconsistencies between finger stick readings and the G7 sensor.
These threads provide detailed, firsthand information from patients. They often share actual blood sugar readings, screenshots, and calibration histories. As more patients report similar experiences, a pattern may emerge that warrants further examination by regulators and manufacturers. The posts capture a day-to-day depiction of how the device performs in real-world settings that may differ from conditions observed in clinical or preapproval studies.
Case Example: GI And Other Symptoms In GLP 1 Drug Communities
While GLP-1 weight loss and diabetes drugs, like Ozempic and Wegovy, have taken the country by storm, stories of serious side effects have popped up online. These are side effects that patients may have been unaware of when they were prescribed the medication. In online communities like r/semaglutide and other GLP-1 forums people have shared stories of severe stomach pain, persistent vomiting and diarrhea, consistent nausea, sulfur burps, and trouble tolerating the medication at higher doses.
It isn’t just patients sharing concerns; clinicians have also posted on forums asking colleagues for input on how to help patients tolerate gastrointestinal side effects related to GLP-1 medications. These posts illustrate how the medications may affect people, and they raise questions about whether the full scope of side effects has been adequately communicated to patients and prescribers.
What The Research Says About Social Media And Safety Signals
Online communities where patients report medication-related issues, have given rise to a new type of monitoring known as social media pharmacovigilance. Studies show that invaluable insight can be gained from social media reporting. It can help to detect adverse drug events long before traditional monitoring systems since patients may be unaware that the side effect is related to the drug, feel more comfortable going online to confirm that others are experiencing similar problems, or be unable to see a healthcare provider in a timely manner.
These online forums have served as early detection systems of side effects and dangers that may not have been apparent in clinical trials or other more formal reporting systems. These systems often rely on self-reporting from manufacturers and healthcare providers which has potentially led to significant underreporting of serious adverse events.
Research indicates that the sheer size and “near-instantaneous nature of social media” presents an opportunity for real-time monitoring that other models simply do not allow.
Strengths And Limits Of Online Patient Communities
While social media may be able to work in conjunction with other reporting mechanisms, it is not meant to replace them. There are strengths in these online forums but there are also limitations. It is important to note that these shared stories are not meant to replace clinical testing or formal studies. They are there to provide insight and potentially serve as an early detection system for adverse events.
Strengths of online patient communities: Online threads provide real-time, near instantaneous reporting from patients around the globe. They are highly accessible and allow patients to report side effects that may not fit neatly within a predefined checkbox, providing a real-world look at how a drug may affect someone on a day-to-day basis.
Limitations of online patient communities: Conversations on social media or other platforms may not give a complete picture. Rarely will a patient give their full medical history on these threads and they usually have not seen a doctor or received lab results before posting. They may only present a select amount of information in order to gauge whether readers have experienced similar problems. This can increase fears about how certain medications behave, without scientific data to back it up. They are incomplete at best, which is why the information should be used as a starting point not a conclusion.
Online platforms should be reviewed with a cautionary approach, they are far from a perfect data source. They can be biased and exaggerated but when used responsibly they can also serve as an early warning system for real problems.
How Online Signals Can Be Utilized In Investigations
In addition to helping regulators and researchers identify emerging prescription drug and medical device problems, online signals can also help product liability attorneys gain additional insight into the real-world behavior of the drug or device.
While these threads may not determine the outcome of a legal case, they can provide lawyers with information to discuss with experts or seek in discovery. They may also point to a specific batch or lot of a product that warrants further investigation or help to narrow the focus of an inquiry.
Guidance For Patients Who Share Their Experiences Online
Individuals who have experienced adverse events while taking a drug or using a medical device are encouraged to document their experience with as much detail as possible. Keep a detailed record of the dates of use, doses, and any recommendations from a doctor or healthcare provider. Save product labeling, marketing material, as well as safety information.
If sharing an experience online, be sure to protect your privacy and avoid making definitive medical claims. Instead, focus on describing symptoms and experiences. Seek medical attention for any new or worsening symptoms.
An online forum should not and does not replace medical care.
Early diagnosis and treatment often proves critical in these cases. In addition to posting online, report any serious side effects through formal monitoring sites such as MedWatch and always consult with a healthcare provider about any concerns.
Why These Early Signals Matter
The widespread use of social media and online communities to report adverse events has helped to identify patterns and serve as an early warning system for potential drug and medical device safety concerns. While not meant to replace science, clinical trials, or formal studies, these platforms can work in conjunction with traditional reporting to bring attention to problems that may not have been fully captured during the approval process or in post-market surveillance.
When enough patients speak up, it increases the likelihood that their voices will be heard. It can help to influence regulatory action and may provide unique insight for investigators, researchers, and lawyers. Patients are encouraged to continue sharing their experiences online to help ensure that side effects are identified and addressed. Reach out to Wisner Baum for more information.
